HALO Diagnostics
Menlo Park
About HALO Diagnostics
At HALO Diagnostics (HALO Dx), we recognize every patient is unique. Our focus is early detection and precision-focused healthcare, preventing, and conquering diseases that have a geometric impact on patient outcomes. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarker tests, and community-based data at scale combined with deep learning algorithms. By optimizing these solutions under the HALO Dx platform, we provide precise, actionable results to enable life-changing treatments by physicians for their patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $19.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2021)
- Website: halodx.com
- Phone: [email protected]
Industries & Categories
Clinical Trials, Enterprise Software, Health Care, Health Diagnostics, Hospital
Social Profiles
Canonical: https://fsome.com/organization/halo-diagnostics-37865 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.